Pharma sector outlook: ICRA pegs 7-9% revenue growth for FY26, US headwinds cloud prospects
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
Join our WhatsApp Community to receive travel deals, free stays, and special offers!
- Join Now -
India's pharmaceutical sector is poised for strong revenue growth, projecting 7-9% in FY26, driven by domestic and European demand. While US market growth may moderate, operating profit margins are expected to remain resilient. Companies are increasing R&D spending and capital expenditure, focusing on speciality products. What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
